Company news

Codexis, Inc. news in 2026

Codexis, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

September 28, 2026

Codexis to Participate in Cantor Global Healthcare Conference 2026

August 27, 2026

Codexis Reports Second Quarter 2026 Financial Results

August 11, 2026

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

August 3, 2026

Codexis to Report Second Quarter 2026 Financial Results on August 11

July 28, 2026

Codexis Announces Proposed Public Offering of Common Stock - July 23, 2026

July 27, 2026

Codexis Announces Pricing of Public Offering of Common Stock - July 23, 2026

July 27, 2026

Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA

May 20, 2026

Codexis Reports First Quarter 2026 Financial Results

May 7, 2026

Codexis to share RNA manufacturing advances at TIDES USA

April 29, 2026

Codexis to Report First Quarter 2026 Financial Results on May 7

April 23, 2026

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

March 10, 2026

Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

March 4, 2026

Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11

February 24, 2026

Codexis to Participate in TD Cowen 46th Annual Health Care Conference

February 17, 2026

Codexis Achieves ISO 9001: 2015 Certification

February 10, 2026

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

January 6, 2026

Calls in 2026

Decks in 2026